Pure Global AI
CDSCO UID IMP/IVD/2023/000036_ec49f76842818d87491c60bd0188b222_ec301a0cd04a11141e774ad31afccfaf

Anti-Cardiolipin IgM (Maglumi Anti-Cardiolipin IgM )

SNIBE DIAGNOSTIC (India) Private Limited.Device Class Class BIndia CDSCOBrand: MAGLUMI® Tip
VerifiedCDSCO · official registry
Registration details
UID
IMP/IVD/2023/000036_ec49f76842818d87491c60bd0188b222_ec301a0cd04a11141e774ad31afccfaf
Device class
Class B
Brand name
MAGLUMI® Tip
Approving authority
CDSCO
Product information
The kit is an in vitro chemiluminescence immunoassay for the quantitative determination of Anti-Cardiolipin IgM (MAGLUMI® Tip) in human serum and plasma
About this record

Anti-Cardiolipin IgM (Maglumi Anti-Cardiolipin IgM ) is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2023/000036_ec49f76842818d87491c60bd0188b222_ec301a0cd04a11141e774ad31afccfaf. This device is marketed under the brand name MAGLUMI® Tip. The license holder is SNIBE DIAGNOSTIC (India) Private Limited., and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides the facts attached to this CDSCO registry row. Other records from the same license holder are available through the database search link without adding aggregation queries to this page. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.